
Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility
Keywords: OCCs; ovarian cancer cells; DS; drug-sensitive; CisR; cisplatin-resistant; PacR; paclitaxel-resistant; Dual; dual drug-resistant; MMPs; matrix metalloproteinases; pMLC; phosphorylated myosin light chain; MLC; myosin light chain; GM; GM6001; NMM II; non-mu